Correlation Between Caribou Biosciences and Sellas Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Sellas Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Sellas Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Sellas Life Sciences, you can compare the effects of market volatilities on Caribou Biosciences and Sellas Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Sellas Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Sellas Life.

Diversification Opportunities for Caribou Biosciences and Sellas Life

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between Caribou and Sellas is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Sellas Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sellas Life Sciences and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Sellas Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sellas Life Sciences has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Sellas Life go up and down completely randomly.

Pair Corralation between Caribou Biosciences and Sellas Life

Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Sellas Life. But the stock apears to be less risky and, when comparing its historical volatility, Caribou Biosciences is 1.33 times less risky than Sellas Life. The stock trades about -0.15 of its potential returns per unit of risk. The Sellas Life Sciences is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  109.00  in Sellas Life Sciences on October 10, 2024 and sell it today you would lose (4.00) from holding Sellas Life Sciences or give up 3.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.24%
ValuesDaily Returns

Caribou Biosciences  vs.  Sellas Life Sciences

 Performance 
       Timeline  
Caribou Biosciences 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Caribou Biosciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental drivers, Caribou Biosciences may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Sellas Life Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sellas Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Caribou Biosciences and Sellas Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Caribou Biosciences and Sellas Life

The main advantage of trading using opposite Caribou Biosciences and Sellas Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Sellas Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sellas Life will offset losses from the drop in Sellas Life's long position.
The idea behind Caribou Biosciences and Sellas Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories